362 related articles for article (PubMed ID: 34771746)
1. Interplay between Cellular and Non-Cellular Components of the Tumour Microenvironment in Hepatocellular Carcinoma.
Sükei T; Palma E; Urbani L
Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771746
[TBL] [Abstract][Full Text] [Related]
2. Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy.
Liu Y; Xun Z; Ma K; Liang S; Li X; Zhou S; Sun L; Liu Y; Du Y; Guo X; Cui T; Zhou H; Wang J; Yin D; Song R; Zhang S; Cai W; Meng F; Guo H; Zhang B; Yang D; Bao R; Hu Q; Wang J; Ye Y; Liu L
J Hepatol; 2023 Apr; 78(4):770-782. PubMed ID: 36708811
[TBL] [Abstract][Full Text] [Related]
3. Modulation of the tumour microenvironment in hepatocellular carcinoma by tyrosine kinase inhibitors: from modulation to combination therapy targeting the microenvironment.
Chen R; Li Q; Xu S; Ye C; Tian T; Jiang Q; Shan J; Ruan J
Cancer Cell Int; 2022 Feb; 22(1):73. PubMed ID: 35148789
[TBL] [Abstract][Full Text] [Related]
4. Three-dimensional (3D) cell culture: a valuable step in advancing treatments for human hepatocellular carcinoma.
Khafaga AF; Mousa SA; Aleya L; Abdel-Daim MM
Cancer Cell Int; 2022 Jul; 22(1):243. PubMed ID: 35908054
[TBL] [Abstract][Full Text] [Related]
5. Current Strategies for the Treatment of Hepatocellular Carcinoma by Modulating the Tumor Microenvironment via Nano-Delivery Systems: A Review.
Huang Y; Wang T; Yang J; Wu X; Fan W; Chen J
Int J Nanomedicine; 2022; 17():2335-2352. PubMed ID: 35619893
[TBL] [Abstract][Full Text] [Related]
6. Fueling HCC Dynamics: Interplay Between Tumor Microenvironment and Tumor Initiating Cells.
Huang H; Tsui YM; Ng IO
Cell Mol Gastroenterol Hepatol; 2023; 15(5):1105-1116. PubMed ID: 36736664
[TBL] [Abstract][Full Text] [Related]
7. Cirrhotic Human Liver Extracellular Matrix 3D Scaffolds Promote Smad-Dependent TGF-β1 Epithelial Mesenchymal Transition.
Mazza G; Telese A; Al-Akkad W; Frenguelli L; Levi A; Marrali M; Longato L; Thanapirom K; Vilia MG; Lombardi B; Crowley C; Crawford M; Karsdal MA; Leeming DJ; Marrone G; Bottcher K; Robinson B; Del Rio Hernandez A; Tamburrino D; Spoletini G; Malago M; Hall AR; Godovac-Zimmermann J; Luong TV; De Coppi P; Pinzani M; Rombouts K
Cells; 2019 Dec; 9(1):. PubMed ID: 31905709
[TBL] [Abstract][Full Text] [Related]
8. The role of tumor microenvironment reprogramming in primary liver cancer chemotherapy resistance.
Zhao C; Liu S; Gao F; Zou Y; Ren Z; Yu Z
Front Oncol; 2022; 12():1008902. PubMed ID: 36505831
[TBL] [Abstract][Full Text] [Related]
9. Interdependent and independent multidimensional role of tumor microenvironment on hepatocellular carcinoma.
Wang X; Hassan W; Jabeen Q; Khan GJ; Iqbal F
Cytokine; 2018 Mar; 103():150-159. PubMed ID: 29029799
[TBL] [Abstract][Full Text] [Related]
10. 3D-3-culture: A tool to unveil macrophage plasticity in the tumour microenvironment.
Rebelo SP; Pinto C; Martins TR; Harrer N; Estrada MF; Loza-Alvarez P; Cabeçadas J; Alves PM; Gualda EJ; Sommergruber W; Brito C
Biomaterials; 2018 May; 163():185-197. PubMed ID: 29477032
[TBL] [Abstract][Full Text] [Related]
11. Hepatic Stellate Cells and Hepatocarcinogenesis.
Barry AE; Baldeosingh R; Lamm R; Patel K; Zhang K; Dominguez DA; Kirton KJ; Shah AP; Dang H
Front Cell Dev Biol; 2020; 8():709. PubMed ID: 32850829
[TBL] [Abstract][Full Text] [Related]
12. How does the tumor microenvironment play a role in hepatobiliary tumors?
Kamil F; Rowe JH
J Gastrointest Oncol; 2018 Feb; 9(1):180-195. PubMed ID: 29564184
[TBL] [Abstract][Full Text] [Related]
13. Tumor Microenvironment of Hepatocellular Carcinoma: Challenges and Opportunities for New Treatment Options.
Sas Z; Cendrowicz E; Weinhäuser I; Rygiel TP
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409139
[TBL] [Abstract][Full Text] [Related]
14. The extracellular matrix in hepatocellular carcinoma: Mechanisms and therapeutic vulnerability.
Roy AM; Iyer R; Chakraborty S
Cell Rep Med; 2023 Sep; 4(9):101170. PubMed ID: 37652015
[TBL] [Abstract][Full Text] [Related]
15. Exosome-mediated communication in the tumor microenvironment contributes to hepatocellular carcinoma development and progression.
Wu Q; Zhou L; Lv D; Zhu X; Tang H
J Hematol Oncol; 2019 May; 12(1):53. PubMed ID: 31142326
[TBL] [Abstract][Full Text] [Related]
16. Tumor microenvironment signaling and therapeutics in cancer progression.
Goenka A; Khan F; Verma B; Sinha P; Dmello CC; Jogalekar MP; Gangadaran P; Ahn BC
Cancer Commun (Lond); 2023 May; 43(5):525-561. PubMed ID: 37005490
[TBL] [Abstract][Full Text] [Related]
17. Recreating Tumour Complexity in a Dish: Organoid Models to Study Liver Cancer Cells and their Extracellular Environment.
van Tienderen GS; Groot Koerkamp B; IJzermans JNM; van der Laan LJW; Verstegen MMA
Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31683901
[TBL] [Abstract][Full Text] [Related]
18. The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: New challenges and therapeutic opportunities.
Mehraj U; Ganai RA; Macha MA; Hamid A; Zargar MA; Bhat AA; Nasser MW; Haris M; Batra SK; Alshehri B; Al-Baradie RS; Mir MA; Wani NA
Cell Oncol (Dordr); 2021 Dec; 44(6):1209-1229. PubMed ID: 34528143
[TBL] [Abstract][Full Text] [Related]
19. Single-cell RNA sequencing highlights the role of PVR/PVRL2 in the immunosuppressive tumour microenvironment in hepatocellular carcinoma.
Li A; Ji B; Yang Y; Ye B; Zhu Q; Hu X; Liu Y; Zhou P; Liu J; Gao R; Zhou Q; Kang B; Jiang Y
Front Immunol; 2023; 14():1164448. PubMed ID: 37383234
[TBL] [Abstract][Full Text] [Related]
20. A review concerning the breast cancer-related tumour microenvironment.
Rodríguez-Bejarano OH; Parra-López C; Patarroyo MA
Crit Rev Oncol Hematol; 2024 Jul; 199():104389. PubMed ID: 38734280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
